http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2308a052fc7e7cea7740904534dbba0c
Outgoing Links
Predicate | Object |
---|---|
family-name | Merkenschlager |
name | Matthias Merkenschlager |
given-name | Matthias |
organization-name | Lymphocyte Development Group 1 and 2; Epigenetics Section, MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College London, London W12 0NN, England, UK 1 and 2; Lymphocyte Development Group 1 and 2; Epigenetics Section, MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College London, London W12 0NN, England, UK 1 and 2 MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College London, London W12 0NN, United Kingdom; Lymphocyte Development Group, Medical Research Council Clinical Sciences Centre, Faculty of Medicine, Imperial College London, London, United Kingdom; and 1Lymphocyte Development Group, Medical Research Council Clinical Sciences Centre From the *Lymphocyte Development Group, Medical Research Council Clinical Sciences Centre, Royal Postgraduate Medical School, Hammersmith Hospital, London W12 0NN, United Kingdom; and ‡Division of Molecular Immunology, National Institute of Medical Research, London, United Kingdom MRC Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital Campus, Du Cane Road, London W12 0NN, UK. *Lymphocyte Development Group and Lymphocyte Development Group, MRC Clinical Sciences Center, Faculty of Medicine, Imperial College London, London, UK Lymphocyte Development Group, MRC Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK 1Lymphocyte Development Group, ‡Lymphocyte Development Group, Medical Research Council Clinical Sciences Centre, Imperial College London, London, U.K. Lymphocyte Development Group and 1Lymphocyte Development Group, MRC Clinical Sciences Centre, ICSM Hammersmith Hospital, London W12 0NN, UK Lymphocyte Development Group, Medical Research Council Clinical Sciences Centre, Imperial College London, London W12 0NN, England, UK 1 Lymphocyte Development Group, Medical Research Council Clinical Sciences Center, Imperial College London, Du Cane Road, London W12 0NN, United Kingdom Lymphocyte Development Group, Medical Research Center Clinical Sciences Centre, Imperial College London, London W12 0NN, United Kingdom; and M. Merkenschlager is at the Lymphocyte Development Group, Medical Research Council Clinical Sciences Centre, Imperial College London, London W12 0NN, UK Lymphocyte Development Group, MRC Clinical Sciences Centre Imperial College London Du Cane Road London W12 0NN UK Lymphocyte Development Group, MRC Clinical Sciences Centre, Imperial College London, London W12 0NN, United Kingdom; and 1Lymphocyte Development Group, MRC Clinical Sciences Centre Lymphocyte Development Group, MRC, Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital, Du Cane Road, London, W12 0NN, UK Lymphocyte Development Group, MRC Clinical Sciences Centre, Imperial College London, Hammersmith Hospital, Du Cane Road, London, W12 0NN, UK Lymphocyte Development Group, MRC Clinical Sciences Centre, Imperial College, Du Cane Road, London W12 ONN, United Kingdom Lymphocyte Development Group, and; Epigenetics Section, MRC Clinical Sciences Centre, Faculty of Medicine, Imperial College London, London, United Kingdom; Lymphocyte Development Group, Gene Regulation and Chromatin Group, Haemostasis Group, Transplantation Biology Group, and Membrane Transport Biology Group, Medical Research Council Clinical Sciences Centre, Faculty of Medicine, Imperial College of Science, Technology, and Medicine, Hammersmith Hospital Campus, Du Cane Road, London W12 ONN, United Kingdom; and Institute of Cell, Animal, and Population Biology, University of Edinburgh, West Mains Road, Edinburgh EH9 3JT, United Kingdom 1Lymphocyte Development Group, Medical Research Council Clinical Sciences Centre, Imperial College London, London W12 0NN, England, UK MRC Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital Campus London UK Lymphocyte Development Group, MRC Clinical Sciences Centre, Imperial College Faculty of Medicine, Hammersmith Campus, London W12 0NN, United Kingdom |
Incoming Links
Total number of triples: 153.